AltaThera Pharmaceuticals, a hospital specialty pharmaceutical company focused on commercializing innovative drugs aimed at improving outcomes and reducing hospital costs, chose Dexur’s App Suite to help scale the operations of the company. AltaThera recently received approval from the FDA for new indications of Sotalol IV, to help hospitals manage patients with Afib.
“We chose Dexur because it integrates the myriad of applications such as CRM, Sales Reporting, Medical Information Request (MIRF) and Sunshine Reporting into a single platform that our sales, commercial and other operations can utilize to scale” said Jodi Devlin, AltaThera's CEO
Altathera’s use of Dexur Apps include:
Dexur not only brings the core applications but also the implementation services to customize it to fit the precise needs of Altathera. Unlike, other technology platforms where the implementation services are disconnected underlying technology. This helps Altathera manage costs while scaling the operations of the operations effectively.
About Dexur: Dexur provides technology and data solutions to Life Sciences, Hospitals, and healthcare organizations. Dexur's Life Sciences App suite provides a comprehensive set of applications to help Biopharma, Medical Device, and Life Sciences companies scale effectively.